Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Clinical trial NCT01019616 · UNKNOWN

Trial details

NCT number: NCT01019616
Sponsor: Tao OUYANG
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Breast Cancer

Start date: 2011-03-04
Primary completion: 2022-06-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.